Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2016

Sep 9, 2016

30786_dirs_2016-09-09_c559146c-be81-4e4c-9153-74d16a920af4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-09-07

Reporting Person: Hall Shannon (Executive Vice President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-09-07 Restricted Stock Units $0 A 3000 Acquired Bio-Rad A Common Stock (3000) Direct
2016-09-07 Non-Qualified Stock Option (right to buy) $159.32 A 3000 Acquired 2026-09-07 Bio-Rad A Common Stock (3000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 427.012 Direct

Footnotes

F1: Includes 91.2231 shares acquired under the Bio-Rad Laboratories employee stock purchase plan on June 30, 2016.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.